Biochemistry of alcoholic liver disease.
The biochemistry of alcohol liver disease as it relates to clinical medicine and experimental alcohol liver disease is presented. Clinical features are emphasized in the diagnosis of alcohol liver disease, particularly as it relates to staging the disease and predictors of prognosis. Currently, it is true that the biochemical diagnosis of alcohol liver disease is at best very limited in terms of the sensitivity tests and specificity of the test. It is particularly difficult to detect alcohol liver disease biochemically in the early stages when steatohepatitis is not severe. Consequently, 50% of the patients have already developed cirrhosis at the time they are diagnosed clinically. In this review indicators of malnutrition are emphasized because they have the strongest implications regarding survival during the acute hospitalization stage of the disease. They are also the best indicators of response to therapy during the recovery phase. With respect to experimental work on the pathogenesis of alcohol liver disease, it appears that necrosis is due to the inability to increase blood flow to compensate for increased oxygen utilization. The hypothesis that mitochondrial damage is the cause of liver cell damage is regarded as less important in the pathogenesis of necrosis. The shift in the redox state during alcohol metabolism accounts for the fatty change noted in the central lobular area of the liver in animals fed alcohol. Apparently, there is strong experimental evidence that highly reactive intermediates are important in the pathogenesis of liver damage due to the induction of the isozyme cytochrome P450 IIE1 by alcohol ingestion. This mechanism is enhanced by a diet high in polyunsaturated fatty acids.
French
S W
SW
Department of Pathology, Harbor-UCLA Medical Center, Torrance.
D000818:Animals; D003094:Collagen / Q000378:metabolism; D004798:Enzymes / Q000097:blood; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D008108:Liver Diseases, Alcoholic / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism*; D008954:Models, Biological; D009748:Nutrition Disorders / Q000150:complications; D011379:Prognosis; D017382:Reactive Oxygen Species / Q000378:metabolism
D004798:Enzymes; D007070:Immunoglobulin A; D017382:Reactive Oxygen Species; D003094:Collagen